Kidney Affection in Non Alcaholic Fatty Liver Diseases
Early Detection of Kidney Affection in Non Alcaholic Fatty Liver Diseases(NAFLD)
1 other identifier
observational
114
1 country
2
Brief Summary
Early detection of renal affection in patients with non alcaholic fatty liver diseases using microalbuminuria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2020
CompletedFirst Posted
Study publicly available on registry
February 18, 2020
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFebruary 23, 2022
February 1, 2020
1 year
February 14, 2020
February 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Early detection of kidney affection in non alcaholic fatty liver diseases
Finding patients with non alcaholic fatty liver diseases who develop renal impairment
Baseline
Interventions
Detection of microalbumin in urine
Eligibility Criteria
All pateints with fatty liver diseases diagnosed by ultrasonography and lab investigation
You may qualify if:
- All patients with fatty liver disease diagnosed by abdominal ultrasonogarphy .
- All patients with fatty liver disease diagnosed by lab investigations.
You may not qualify if:
- Diabetic patients
- Hypertensive patients
- patients with chronic kidney disesase
- patient with systemic diseases or chronic liver diseases affecting kidneys.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Assiut university
Asyut, Egypt
AssiutU
Asyut, Egypt
Related Publications (3)
Arase Y, Suzuki F, Kobayashi M, Suzuki Y, Kawamura Y, Matsumoto N, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto Y, Amakawa K, Tsuji H, Hsieh SD, Kato K, Tanabe M, Ogawa K, Hara S, Kobayashi T. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. Intern Med. 2011;50(10):1081-7. doi: 10.2169/internalmedicine.50.5043. Epub 2011 May 1.
PMID: 21576832BACKGROUNDKiapidou S, Liava C, Kalogirou M, Akriviadis E, Sinakos E. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? Ann Hepatol. 2020 Mar-Apr;19(2):134-144. doi: 10.1016/j.aohep.2019.07.013. Epub 2019 Sep 23.
PMID: 31606352BACKGROUNDPark H, Dawwas GK, Liu X, Nguyen MH. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. J Intern Med. 2019 Dec;286(6):711-722. doi: 10.1111/joim.12964. Epub 2019 Aug 23.
PMID: 31359543BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
February 14, 2020
First Posted
February 18, 2020
Study Start
March 1, 2020
Primary Completion
March 1, 2021
Study Completion
June 1, 2021
Last Updated
February 23, 2022
Record last verified: 2020-02